AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article

How toxic are gold nanoparticles? The state-of-the-art

Ilaria Fratoddi1( )Iole Venditti1Cesare Cametti2Maria Vittoria Russo1
Dipartimento di ChimicaUniversita' di Roma "La Sapienza"Piazzale A. Moro 5, I-00185, RomeItaly
Dipartimento di Fisica and INFM CNR-SOFTUniversita' di Roma "La Sapienza"Piazzale A. Moro 5, I-00185, RomeItaly
Show Author Information

Graphical Abstract

Abstract

With the growing interest in the applications of gold nanoparticles in biotechnology and their physiological effects, possible toxicity of gold nanoparticles is becoming an increasingly important issue. A large number of studies carried out over the past few years under a variety of experimental conditions and following different protocols have produced conflicting results, leading to divergent views about the actual safety of gold nanoparticles in human applications.

This work is intended to provide an overview of the most recent experimental results and thereby summarize current state-of-the-art. Rather than presenting a comprehensive review of the available literature in this field, which would be impractically broad, we have selected representative examples of both in vivo and in vitro studies, which clearly demonstrate the need for urgent and rigorous standardization of experimental protocols. Despite their significant potential, the safety of gold nanoparticles is highly controversial at this time, and important concerns have been raised that need to be properly addressed. Factors such as shape, size, surface charge, coating, and surface functionalization are expected to influence the interactions of particles with biological systems to a different extent, resulting in different outcomes and influencing the potential of gold nanoparticles for biomedical applications.

Moreover, despite continuous attempts to establish a correlation between structure of the particles and their interactions with biological systems, we are still far from elucidating the toxicological profile of gold nanoparticles in an indisputable manner. This review is intended to contribute towards this goal, offering a number of suggestions on how to achieve the systematization of data on the most relevant physico-chemical parameters, which govern and control the toxicity of gold nanoparticles at cellular and whole-organism levels.

References

1

Timbrell, J. A. Biomarkers in toxicology. Toxicology 1998, 129, 1-12.

2

Schmid, O.; Möller, W.; Semmler-Behnke, M.; Ferron, G. A.; Karg, E.; Lipka, J.; Schulz, H.; Kreyling, W. G.; Stoeger, T. Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers 2009, 14, 67-73.

3

Grass, R. N.; Limbach, L. K.; Athanassiou, E. K.; Stark, W. J. Exposure of aerosols and nanoparticle dispersions to in vitro cell cultures: A review on the dose relevance of size, mass, surface and concentration. J. Aerosol Sci. 2010, 41, 1123-1142.

4

Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M. Gold nanoparticles in delivery applications. Adv. Drug. Delivery Rev. 2008, 60, 1307-1315.

5

Eck, W.; Nicholson, A. I.; Zentgraf, H.; Semler, W.; Bartling S. N. Anti-cd4-targeted gold nanoparticles induce specific contrast enhancement on peripheral lymphonodes in x-ray computed tomography in live mice. Nano Lett. 2010, 10, 2318-2322.

6

Bhattacharya, R.; Mukherjee, P. Biological properties of "naked" metal nanoparticles. Adv. Drug. Delivery Rev. 2008, 60, 1289-1306.

7

Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1, 325-327.

8

Dobrovolskaia, M. A.; McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478.

9

Patra, H. K.; Banerjee, S.; Chaudhuri, U.; Lahiri, P.; Dasgupta, A. K. Cell selective response to gold nanoparticles. Nanomedicine 2007, 3, 111-119.

10

Peng, G.; Tisch, U.; Adams, O.; Hakim, M.; Shehada, N.; Broza, Y. Y.; Billan, S.; Abdah-Bortnyad, R.; Kuten, R.; Haick, H. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechnol. 2009, 4, 669-673.

11

Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3, 1941-1949.

12

Zhang, X. D.; Guo, M. L.; Wu, H. Y.; Sun, Y. M.; Ding, Y. Q.; Feng, X.; Zhang, L. A. Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy. Int. J. Nanomedicine 2009, 4, 165-173.

13

Sung, J. H.; Ji, J. H.; Park, J. D.; Song, M. Y.; Song, K. S.; Ryu, H. R.; Yoon, J. U.; Jeon, K. S.; Jeong, J.; Han, B. S. et al. Subchronic inhalation toxicity of gold nanoparticles. Part. Fibre Toxicol. 2011, 8, 16.

14

Villiers, C. L.; Freitas, H.; Couderc, R.; Villiers, M. B.; Marche, P. N. Analysis of the toxicity of gold nano particles on the immune system: Effect on dendritic cell functions. J. Nanopart. Res. 2010, 12, 55-60.

15

Sabella, S.; Galeone, A.; Vecchio, G.; Cingolani, R.; Pompa, P. P. AuNPs are toxic in vitro and in vivo: A review. J. Nanosci. Lett. 2011, 1, 145-165.

16

Wang, S.; Lawson, R.; Ray, P. C.; Yu, H. Toxic effects of gold nanoparticles on salmonella typhimurium bacteria. Toxicol. Ind. Health 2011, 27, 0748233710393395.

17

Zhou, M.; Wang, B. X.; Rozynek, Z.; Xie, Z.; H. Fossum, J. O.; Yu, X. F.; Raaen, S. Minute synthesis of extremely stable gold nanoparticles. Nanotechnology 2009, 20, 505606.

18

Kanduc, D.; Mittelman, A.; Serpico, R.; Sinigaglia, E.; Sinha, A. A.; Natale, C.; Santacroce, R.; Di Corcia, M. G.; Lucchese, A.; Dini, L. et al. Cell death: Apoptosis versus necrosis (review). Int. J. Oncol. 2002, 21, 165-170.

19

Pompa, P. P.; Vecchio, G.; Galeone, A.; Brunetti, V.; Maiorano, G.; Sabella, S.; Cingolani, R. Physical assessment of toxicology at nanoscale: Nano dose-metrics and toxicity factor. Nanoscale 2011, 3, 2889-2897.

20

Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of nanoparticles. Small 2008, 4, 26-49.

21

Yah, C. S. The toxicity of gold nanoparticles in relation to their physicochemical properties. Biomed. Res. 2013, 24, 400-413.

22

Chen, H. J.; Shao, L.; Li, Q.; Wang, J. F. Gold nanorods and their plasmon properties. Chem. Soc. Rev. 2013, 42, 2679-2724.

23

Aillon, K. L.; Xie, Y.; El-Gendy, N.; Berkland, C. J.; Forrest, M. L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Delivery Rev. 2009, 61, 457-466.

24

Khlebtsov, N; Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies. Chem. Soc. Rev. 2011, 40, 1647-1671.

25

Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of nanoparticles. Small 2008, 4, 26-49.

26

Pelley, J. L.; Daar, A. S.; Saner, M. A. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol. Sci. 2009, 112, kfp188.

27

Maurer-Jones, M. A.; Bantz, K. C.; Love, S. A.; Marquis, B. J.; Haynes, C. L. Toxicity of therapeutic nanoparticles. Nanomedicine 2009, 4, 219-241.

28

Hussain, S. M.; Braydich-Stolle, L. K.; Schrand, A. M.; Murdock, K. O.; Yu, R. C.; Mattie, D. M.; Schlager, J. J.; Terrones, M. Toxicity evaluation for safe use of nanomaterials: Recent achievements and technical challenges. Adv. Mater. 2009, 21, 1549-1559.

29

Fadeel B.; Garcia-Bennett, A. E. Better safe than sorry: Understanding properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Delivery Rev. 2010, 62, 362-374.

30

Johnston, H. J.; Hutchison, G.; Christensen, F. M.; Peters, S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro toxicity of silver and gold nanoparticles: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 2010, 40, 328-346.

31

Soenen, S. J.; Rivera-Gil, P.; Montenegro, J. M.; Parak, W. J.; De Smedt, S. C.; Braeckmans, K. Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 2011, 6, 446-465.

32

Rausch, K.; Reuter, A.; Fischer, K.; Schmidt, M. Evaluation of nanoparticle aggregation in human blood serum. Biomacromolecules 2010, 11, 2836-2839.

33

Cui, W. J.; Li, J. R.; Zhang, Y. K.; Rong, H. L.; Lu, W. S.; Jiang, L. Effects of aggregation and the surface properties of gold nanoparticles on cytotoxicity and cell growth. Nanomedicine: NBM 2012, 8, 46-53.

34

Pan, Y.; Neuss, S.; Leifert, A.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3, 1941-1949.

35

Fratoddi, I.; Venditti, I.; Cametti, C.; Palocci, C.; Chronopoulou, L.; Marino, M.; Acconcia, F.; Russo, M. V. Functional polymeric nanoparticles for dexamethasone loading and release. Colloids Surf., B 2012, 93, 59-66.

36

Shukla, S.; Priscilla, A.; Banerjee, M.; Bhonde, R. R.; Ghatak, J.; Satyam, P. V. Porous gold nanospheres by controlled transmetalation reaction: A novel material for application in cell imaging. Chem. Mater. 2005, 17, 5000-5005.

37

Railsback, J. G.; Singh, A.; Pearce, R. C.; McNight, T. E.; Collazo, R.; Sitar, Z.; Yingling, Y. G.; Melechko, A. V. Weakly charged cationic nanoparticles induce DNA bending and strand separation. Adv. Mater. 2012, 24, 4261-4265.

38

Paillusson, F.; Dahirel, V.; Jardat, M.; Victor, J. M.; Barbo, M. Effective interaction between charged nanoparticles and DNA. Phys. Chem. Chem. Phys. 2011, 13, 12603-12613.

39

Poulos, A. S.; Constantin, D.; Davidson, P.; Impéror-Clerc, M.; Pansu, B.; Rouzière, S. The interaction of charged nanoparticles at interfaces. EPL 2012, 100, 18002.

40

Huang, X. L.; Zhang, B.; Ren, L.; Ye, S. F.; Sun, L. P.; Zhang, Q. Q.; Tan, N. C.; Chow, G. M. In vivo toxic studies and biodistribution of near infrared sensitive Au-AuS nanoparticles as potential drug delivery carriers. J. Mat. Sci. : Mater. Med. 2008, 19, 2581-2588.

41

Hainfeld, J. F.; Slatkin, D. N.; Focella, T. M.; Smilowitz, H. M. Gold nanoparticles: A new x-ray contrast agent. Br. J. Radiol. 2006. 79, 248-253,

42

Gerber, A.; Bundschud, M.; Klingelhofer, D.; Groneberg, D. A. Gold nanoparticles: Recent aspects for human toxicology. J. Occup. Med. Toxicol. 2013, 8, 32.

43

Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A. The golden age: Gold nanoparticles for biomedicine. Chem. Soc. Rev. 2012, 41, 2740-2779.

44

Fratoddi, I.; Venditti, I.; Cametti, C.; Russo, M. V. Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges. J. Mater. Chem. B 2014, 2, 4204-4220.

45

Fratoddi, I.; Panziera, N.; Pertici, P.; Martra, G.; Bertinetti, L.; Russo, M. V. Nanostructured gold/conjugated polymer hybrids: Preparation, chemical structure and morphology. Mater. Sci. Engin., C 2007, 27, 1305-1308.

46

Vitale, F.; Piscopiello, E.; Pellegrini, G.; Fratoddi, I.; Russo, M. V.; Tapfer, L.; Mazzoldi, P. Gold nanoclusters-organometallic polymer nanocomposite: Synthesis and characterization. Mater. Sci. Engin, . C 2007, 27, 1300-1304.

47

Vitale, F.; Vitaliano, R.; Battocchio, C.; Fratoddi, I.; Piscopiello, E.; Tapfer, L.; Russo, M. V. Synthesis and characterization of gold nanoparticles stabilized by palladium (Ⅱ) phosphine thiol. J. Organomet. Chem. 2008, 693, 1043-1048.

48

Vitale, F.; Vitaliano, R.; Battocchio, C.; Fratoddi, I.; Giannini, C.; Piscopiello, E.; Guagliardi, A.; Cervellino, A.; Polzonetti, G.; Russo, M. V. et al. Synthesis and microstructural investigations of organometallic Pd(Ⅱ) thiol-gold nano-particles. Nanoscale Res. Lett. 2008, 3, 461-467.

49
Fratoddi, I.; Venditti, I.; Russo, M. V. Breackthroughs for gold nanoparticles: , volume chap. 13. Nova Science Publisher, Inc. NY, 2010. ISBN: 978-1-61668-009-1.
50

Fratoddi, I.; Venditti, I.; Battocchio, C.; Polzonetti, G.; Cametti, C.; Russo, M. V. Core-shell hybrids based on noble metal nanoparticles and conjugated polymers: Synthesis and characterization. Nanoscale Res. Lett. 2011, 6, 98.

51

Cametti, C.; Fratoddi, I.; Venditti, I.; Russo, M. V. Dielectric relaxations of thiol-coated noble metal nanoparticles in aqueous solutions. electrical characterization of the interface. Langmuir, 2011, 27, 7084-7090.

52

Fratoddi, I.; Venditti, I.; Battocchio, C.; Polzonetti, G.; Bondino, F.; Malvestuto, M.; Piscopiello, E.; Tapfer, L.; Russo, M. V. Gold nanoparticle dyads stabilized with binuclear Pt(Ⅱ) dithiol bridges. J. Phys. Chem. C 2011, 115, 15198-15204.

53

Fratoddi, I.; Battocchio, C.; Polzonetti, G.; Sciubba, F.; Delfini, M.; Russo, M. V. A porphyrin bridged Pd dimer complex stabilizes gold nanoparticles. Eur. J. Inorg. Chem. 2011, 4906-4913.

54

Quintiliani, M.; Bassetti, M.; Pasquini, C.; Battocchio, C.; Possi, M.; Mura, F.; Matassa, R.; Fontana, L.; Russo, M. V.; Fratoddi, I. Network assembly of gold nanoparticles linked through fluorenyl dithiol bridge. J. Mater. Chem. C 2014, 2, 2517-2527.

55

Venditti, I.; Fontana, L.; Fratoddi, I.; Battocchio, C.; Cametti, C.; Sennato, S.; Mura, F.; Sciubba, F.; Delfini, M.; Russo, M. V. Direct interaction of hydrophilic gold nanoparticles with dexamethasone drug: Loading and release study. J. Colloid Interf. Sci. 2014, 418, 52-60.

56

Battocchio, C.; Fratoddi, I.; Venditti, I.; Yarzhemsky, V. G.; Norov, Y. V.; Russo, M. V.; Polzonetti, G. Exafs in total refelexion (reflexafs) for the study of organometallic Pd(Ⅱ) thiol complexes based self-assembled monolayers on gold. Chem. Phys. 2011, 379, 92-98.

57

Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. 2007, 46, 5754-5756.

58

Lynch, I.; Cedervall, T.; Lundqvist, M.; Cabaleiro-Lago, C.; Linse, S.; Dawson, K. A. The nanoparticle-protein complex as a biological entity; A complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 2007, 134-135, 167-174.

59

Lynch I.; Dawson, K. A. Protein-nanoparticle interactions. Nano Today, 2008, 3, 40-47.

60

Casals, E.; Pfaller, T.; Duschl, A.; Oosting, G. J.; Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010, 4, 3623-3632.

61

Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bandelli-Bombelli, F.; Dawson, K. A. Physical-chemical aspects of the protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525-3534.

62

Perdonet, N.; Fang, X.; Sun, Y.; Bakhtina, A.; Ramakrishnan, A.; Sokolov, J.; Ulman, A.; Rafailovih, M. Adverse effects of citrate-gold nanoparticles on human dermal fibroblasts. Small 2006, 2, 766-773.

63

Rivera Gil, P.; Huhn, D.; del Mercato, L. L.; Sasse, D.; Parak, W. J. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacol. Res. 2010, 62, 115125.

64

Chitharani, B. D.; Ghazani, A. A.; Chan, W. C. W. Determining the size and the shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6, 662-668.

65

Murphy, C. J.; Stone, J. W.; Sisco, P. N.; Alkilany, A. M.; Goldsmith, E. C.; Baxter, S. C. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc. Chem. Res. 2008, 41, 1721-1730.

66

De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; Sips, A. J. A. M.; Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticlesafter intravenous injection. Biomaterials 2008, 29, 1912-1919.

67

Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf., B 2008, 66, 274-280.

68

Abdel Halim, M. A. The influence of size and exposure duration of gold nanoparticles on gold nanoparticle levels in several rat organs in vivo. J. Cell Sci. Ther. 2012, 3, 1000129.

69

Pompa, P. P.; Vecchio, G.; Galeone, A.; Brunetti, V.; Sabella, S.; Maiorano, G.; Falqui, A.; Bertoni, G.; Congolani, R. In vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster. Nano Res. 2011, 4, 405-413.

70

Simpson, C. A.; Salleng, K. J.; Cliffel, D. E.; Feldheim, D. L. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine: NBM 2013, 9, 257-263.

71

Simpson, C. A.; Huffman, B. J.; Gerdon, A. E.; Cliffel, D. E. Unexpected toxicity of mono layer protected gold clusters eliminated by PEG-thiol place exchange reactions. Chem. Res. Toxicol. 2010, 23, 1608-1616.

72

Cazacu, A.; Bindar, D.; Tartau, L.; Hritcu, L.; Stefan, M.; Nita, L.; Ionescu, C.; Nica, V.; Rusu, G.; Dobromir, M. et al. Effect on nerve structures of functionalized gold-chitosan nanoparticles obtained by one pot synthesis. An. Stiint. Univ. "Alexandru Ioan Cuza" Iasi, Sect. Ⅱ a: Genet. Biol. Mol. 2011, 12, 45-49.

73

Esumi, K.; Takei, N.; Yoshimura, T. Antioxidant potentiality of gold-chitosan nanocomposites. Colloids Surf. B 2003, 32, 117-123.

74

Stefan, M.; Melnig, V.; Pricop, D.; Neagu, A.; Mihasan, M.; Tartu, L. Attenuated effects of chitosan-capped gold nanoparticles on LPS-induced toxicity in laboratory rats. Mater. Sci. Eng. C 2013, 33, 550-556.

75

Coradeghini, R.; Gioria, S.; Garcia, C. P.; Nativo, P.; Franchini, F.; Gilliland, D.; Ponti, J.; Rossi, F. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicology Lett. 2013, 217, 205-216.

76

Yamada K. M.; Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130, 601-610.

77

Lee, J.; Lilly, G. D.; Doty, R. C.; Podsiadlo, P.; Kotov, N. A. In vitro toxicity testing of nanoparticles in 3D cell culture. Small 2009, 5, 1213-1221.

78

Ponti, J.; Colognato, R.; Rauscher, H.; Gloria, S.; Broggi, F.; Franchini, F.; Pascual, C.; Guidetti, G.; Rossi, F. Colony forming efficiency and microscopy analysis of multi-well carbon nanotubes cell interactions. Toxicology Lett. 2010, 197, 29-37.

79

Chen, Y. S.; Hung, Y. C.; Iau, I.; Huang, G. S. Assessement of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett. 2009, 4, 858-864.

80

Sun, L. L.; Liu, D. J.; Wang, Z. X. Functional gold nanoparticle-peptide complexes as cell targeting agents. Langmuir 2008, 24, 10293-10297.

81

Tkachenko, A. G.; Xie, H.; Liu, Y.; Coleman, D.; Ryan, J.; Glomn, W. R.; Shipton, M. K.; Franzen, S.; Feldheim, D. L. Cellular traiectories of peptide modified gold particle complexes: Comparison of nuclear localization signals and peptide tranduction domain. Bioconjugate Chem. 2004, 15, 482-490.

82

Khan, J. A.; Pillai, B.; Das, T. K.; Singh, Y.; Maiti, S. Molecular effects of uptake of gold nanoparticles in hela cells. Chem. Biochem. 2007, 8, 1237-1240.

83

Kuo, C. W.; Lai, J. J.; Wei, K. H.; Chen, P. Studies of surface modified gold nanowires inside living cells. Adv. Funct. Mater. 2007, 17, 3707-3714.

84

Niidome, T.; Yamagata, M.; Okamoto, Y.; Akiyama, Y.; Takahashi, H.; Kawano, T.; Katayama, Y.; Niidome, Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Controlled Rel. 2006, 114, 343-347.

85

Takahashi, H.; Niidome, Y.; Niidome, T.; Kaneko, K.; Kawasaki, H.; Yamada, S. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir 2006, 22, 2-5.

86

Hauck, T. S.; Ghazani, A. A.; Chan, W. C. W. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008, 4, 153-159.

87

Salmaso, S.; Caliceti, P.; Amendola, V.; Meneghetti, M.; Magnusson, J. P.; Pasparakis, G.; Alexander, C. Cell up-take control of gold nanoparticles functionalized with thermoresponsive polymers. J. Mater. Chem. 2009, 19, 1608-1615.

88

Qu Y. H.; Lü, X. Y. Aqueous synthesis of gold nanoparticles and their cytotoxicity in human dermal fbroblasts fetal. Biomed. Mater. 2009, 4, 025007.

89

Patra, H. K.; Dasgupta, A. K. Cancer cell response to nanoparticles: Criticality and optimality. Nanomed. Nanotech. Biol. Med. 2012, 8, 842-852

90

Pérez-Juste, J.; Pastoriza-Santos, I.; Liz-Marzán, L. M.; Mulvaney, P. Gold nanorods: Synthesis, characterization and applications. Coordination Chem. Rev. 2005, 249, 1870-1901.

91

Alkilany, A. M.; Nagaria, P. K.; Hexel, C. R.; Shaw, T. J.; Murphy, C. J.; Wyatt, M. D. Cellular uptake and cytotoxicity of gold nanorods: Molecular origin of cytotoxicity and surface effects. Small 2009, 5, 701-708.

92

Huff, T. B.; Hansen, M. N.; Zhao, Y.; Cheng, J. X.; Wei, A. Controlling the cellular uptake of gold nanorods. Langmuir 2007, 23, 1596-1599.

93

Alkilany, A. M.; Shatanawi, A.; Kurtz, T.; Caldwell, R. B.; Caldwell, R. W. Toxicity and cellular uptake of gold nanorods in vascular endothelium and smooth muscles of isolated rat blood vessel: Importance of surface modification. Small 2012, 8, 1270-1278.

94

Cortesi, R.; Esposito, E.; Menegatti, E.; Gambari, R.; Nastruzzi, C. Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried dna. Int. J. Pharm. 1996, 139, 69-78.

95

Mirska, D.; Schirmer, K.; Funari, S.; Langner, A.; Dobner, B.; Brezesinski, B. Biophysical and biochemical properties of a binary lipid mixture for dna transfection. Colloids Surf. B 2005, 40, 51-59.

96

Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Prot. Natl. Acad. Sci. U.S.A. 2003, 100, 13549-13554.

97

Loo, C.; Lowery, A.; Halas, N.; West, J.; Drezek, R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005, 5, 709-711.

98

James, W. D.; Hirsch, L. R.; West, J. L.; O'Neal, P. D.; Payne, J. D. Application of inaa to the build-up and clearance of gold nanoshells in clinical studies in mice. J. Radioanal. Nucl. Chem. 2007, 271, 455-459.

99

Khlebtsov, N. G.; Dykman, L. A.; Terentyuk, G. S. Iii euroasian congress on medical physics and engineering. In Moscow State Univ. Publ., editor, Med. l Phys. s 2010, 3, 209-211.

100

Melancon, M. P.; Lu, W.; Yang, Z.; Zhang, R.; Cheng, Z.; Elliot, A. M.; Stafford, J.; Olson, T.; Zhang, J. Z.; Li, C. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol. Cancer Ther. 2008, 7, 1730-1739.

101

Su, C. H.; Sheu, H. S.; Lin, C. Y.; Huang, C. C.; Lo, Y. W.; Pu, Y. C.; Weng, J. C.; Shieh, D. B.; Chen, J. H.; Yeh, C. S. Nanoshell magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2007, 129, 2139-2146.

102

Xia, Y. N; Li, W. Y.; Cobley, C. M.; Chen, J. Y.; Xia, X. H.; Zhang, Q.; Yang, M. X.; Cho, E. C.; Brown, P. K. Gold nanocages: From synthesis to theranostic applications. Acc. Chem. Res. 2011, 44, 914-924.

103

Dykman, L. A.; Khlebtson, N. G. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem. Soc. Rev. 2012, 41, 2256-2282.

104

Yang, X. M.; Stein, E. W.; Ashkenazi, S.; Wang, L. V. Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. : Nanomed. Nanobiotechnol. 2009, 1, 360-368.

105

Wang, Y. C.; Liu, Y. J.; Luehmann, H.; Xia, X. H.; Ean, D. H.; Cutler, C.; Xia, Y. N. Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett. 2013, 13, 581-585.

106

Kim, C.; Cho, E. C.; Chen, J. Y.; Song, K. H.; Au, L.; Favazza, C.; Zhang, Q.; Cobley, C. M.; Gao, F.; Xia, Y. N. et al. In vivo molecular photoacustic tomography of melanomas targeted by bioconjugated gold nanogages. ACS Nano 2010, 4, 4559-4564.

107

Chen, J. Y.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M. X.; Gidding, M.; Welch, M. J.; Xia, Y. N. Gold nanocages as photothermal transducer for cancer treatment. Small 2010, 6, 811-817.

108

Au, L.; Zhang, Q.; Cobley, C. M.; Gidding, M.; Schwartz, A. G.; Chen, J. Y.; Xia, Y. N. Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 2010, 4, 35-42.

109

Rodriguez-Lorenzo, L.; Alvarez-Puebla, R. A.; Garcia de Abajo, F. J.; Liz-Marzan, L. M. Surface enhanced raman scattering using star-shaped gold colloidal nanoparticles. J. Phys. Chem. C 2010, 114, 7336-7340.

110

Yuan, H.; Khoury, C. G.; Hwang, H.; Wilson, C. M.; Grant, G. A.; Vo-Dinh, T. Gold nanostars: Surfaxctant free synthesis, 3D modelling and two photon photoluminescence imaging. Nanotechnology 2012, 23, 075102.

111

Trigari, S.; Rindi, A.; Margheri, G.; Sottini, S.; Dellapiane, G.; Giorgetti, E. Synthesis and modelling of gold nanostars with tunable morphology and extinction spectrum. J. Mater. Chem. 2011, 21, 6531-6549.

112

Salinas, K.; Kereselidze, Z.; De Luna, F.; Peralta, X. G.; Santamaria, F. Transient extracellular application of nanostars increase hippocampal neuronal activity. J. Nanobiotechnology 2014, 12, 31-38.

113

Navarro, J. R. G.; Manchon, D.; Lerouge, F.; Blanchard, N. P.; Marotte, S.; Leverrier, J.; Marvel, J.; Chaput, F.; Micouin, G.; Gabudean, A. A. et al. Synthesis of pegylated gold nanostares and bipyramids for intracellular uptake. Nanotechnology 2012, 23, 465602.

114

Dam, D. H. M.; Lee, R. C.; Odom, T. W. Improved in vitro efficacy of gold nanoconstructs by increased loading of g-quadruplex aptamer. Nano Lett. 2014, 14, 2843-2848.

115

Dam, D. H. M.; Culver, K. S. B.; Odom, T. W. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types. Mol. Pharmaceutics 2014, 11, 580-587.

116

Hutter, E.; Boridy, S.; Labrecque, S.; Lalancette-Hebert, M.; Kriz, J.; Winnik, F. M.; Maysinger, D. Microglial response to gold nanoparticles. ACS Nano 2010, 4, 2595-2606.

117

Li, W. T.; Sun, X. L.; Wang, Y.; Niu, G.; Chen, X. Y.; Qian, Z. Y.; Nie, L. M. In vivo quantitative photoacustic microscopy of gold nanostar kinetics in mouse organ. Biomed. Optics Express 2014, 5, 2679-2685.

118

Rivera-Gil, P.; Jamenez-de Aberasturi, D.; Wulf, V.; Pelaz, B.; Del Pino, P.; Zhao, Y.; De La Fluente, J. M.; Ruiz de Larramendi, I.; Liang, X. J.; Parak, W. J. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. Acc. Chem. Res. 2013, 46, 743-749.

119

Johnston, H.; Pojana, G.; Zuin, S.; Jacobsen, N. R.; Moller, P.; Loft, S.; Semmler-Behnke, M.; McGuiness, C.; Balharry, D.; Marcomini, A. et al. Engineered nanomaterial risk. essons from completed nanotoxicology studies: Potential solutions to current and future challenges. Crit. Rev. Toxicol. 2013, 43, 1-20.

120

Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A.; Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A. et al. Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment. J. Nanopart. Res. 2011, 13, 2675-2687.

121

Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicity: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823-839.

122

Tedesco, S.; Doyle, H.; Redmond, G.; Sheehan, D. Gold nanoparticles and oxidative stress in mytilus edulis. Marine Environ. Res. 2008, 66, 131-133.

123

Kong, B.; Seog. J. H.; Graham, L. M.; Lee, S. B. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine, 2011, 6, 929-941.

124

Malugin, A.; Ghandehari, H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: A comparative study of rods and spheres. J. Appl. Toxicol. 2010, 30, 212-217.

125

Albanese A.; Chan, W. C. Effect of gold nanoparticles aggregation on cell uptake and toxicity. ACS Nano 2011, 5, 5478-5489.

126

Elsaesser, A.; Howard, C. V. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 2012, 64, 129-137.

127

Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 2010, 267, 89-105.

128

Oberdöster, G.; Mayriard, A.; Donaldson, K.; Castranova, V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; Kreyling, W.; Lai, D. et al. Principles for charcterizing the potential human health effects from exposure to nanoparticles: Elements for a screening strategy. Part. Fibre Toxicol. 2005, 2, 8-1/35.

129

Elsaesser, A.; Taylor, A.; de Yanés, G. S.; McKerr, G.; Kim, E. M.; O'Hare, E.; Howard, C. V. Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. Nanomedicine 2010, 5, 1447-1457.

130

Wittmaack, K. In search of the most relevant parameters for quantifying lung inflannatory response to nanoparticle exposure: Particle number, surface area or what? Environ. Health Perspect. 2007, 115, 187-194.

131

Joris, F.; Manshian, B. B.; Peynshaert, K.; De Smedt, S. C.; Braeckman, K.; Soenen, S. J. Assessing nanoparticle toxicity in cell-dased assays: Influence of the cell culture parameters and optimized models for bridging the in vitro- in vivo gap. Chem. Soc. Rev. 2013, 42, 8339-8359.

132

Rushton, E. K.; Jiang, J.; Leonard, S. S.; Eberly, S.; Castranova, V.; Biswas, P.; Elder, A.; Han, X.; Gelein, R.; Finkelstein, J.; Oberdorster, G. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J. Toxicol. Environ. Health, Part A 2010, 73, 445-461.

133

Gulson. B.; Wong, H. Stable isotopic tracing: A way forward for nanotoxicology. Environ. Health Perspect. 2006, 114, 1486-1488.

134

Wang, L. M.; Li, Y. F.; Zhou, L. J.; Liu, Y.; Meng, L.; Zhang, K.; Wu, X. C.; Zhang, L. L.; Li, B.; Chen, C. Y. Characterization of gold nanorods in vivo by integrated analytical techniques: Their uptake, retention and chemical forms. Anal. Bioanal. Chem. 2010, 396, 1105-1114.

135

Darien, B. J.; Sims, P. A.; Kruse-Elliott, K. T.; Homan, T. S.; Cashwell, R. J.; Albrecht, R. M. Use of colloidal gold and neutron activation in correlative microscopic labeling and label quantitation. Scanning Microsc. 1995, 9, 773-780.

136

Qiu, Y.; Liu, Y.; Wang, L. M.; Xu, L. G.; Bai, R.; Ji, Y. L.; Wu, X. C.; Zhao, Y. L.; Li, Y. F.; Chen, C. Y. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31, 7606-7619.

137

Lehmann, A. D.; Parak, W. J.; Zhang, F.; Ali, Z.; Röcker, C.; Nienhaus, G. U.; Gehr, P.; Rothen-Rutishauser, B. Fluorescent magnetic nanoparticles induce a dose dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 2010, 6, 753-762.

138

Teeguarden, J. G.; Hinderliter, P. M.; Orr, G.; Thrall, B. D.; Pounds, J. G. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95, 300-312.

139

Alvarez, P. J. J.; Colvin, V.; Lead, J.; Stone, V. Research priorities to advance eco-responsible nanotechnology. ACS Nano 2009, 3, 1616-1619.

140

Chithrani, B. D.; Chang, W. C. W. Elucidating the mechanism of cellular uptakeand removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7, 1542-1550.

141

Green, J. J.; Chiu, E.; Leshchiner, E. S.; Shi, J.; Langer, R.; Anderson, D. G. Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells. Nano Lett. 2007, 7, 874-879.

142

Marquis, B. J.; Love, S. A.; Brown, K. L.; Haynes, C. L. Analytical methods to assess nanoparticle toxicity. Analyst 2009, 134, 425-439.

143

Soenen, S. J.; De Cuyper, M. Assessing cytotoxicity of (iron-oxide based) nanoparticles: An overwiew of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol. Imaging 2009, 4, 207-219.

144

Monteiro-Riviere, N. A.; Inman, A. O.; Zhang, L. W. Limitations and relative utility of screening assay to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmcol. 2009, 234, 222-235.

145

Dhawan, A.; Sharma, V. Toxicology assessment of nanoparticles: Methods and challenges. Anal. Bioanal. Chem. 2010, 398, 589-605.

146

Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interfaces. Nat. Mater. 2009, 8, 543-557.

147

Torrano, A. A.; Pereira, A. S.; Oliviera, O. N.; Barros-Timmons, A. Probing the interactions of oppositely charged gold nanoparticles with dppg and dppc langmuir monolayers as cell membrane models. Colloids Surf., B 2013, 108, 120-126.

148

Negoda, A.; Liu, Y.; Hou, W. C.; Corredor, C.; Moghadam, B. Y.; Mussolf, C.; Li, W.; Walker, L.; Westerhoff, P.; Mason, A. J. et al. Engineered nanomaterials interactions with bilayer lipid membranes: Screening platforms to assess nanoparticle toxicity. Int. J. Biomed. Nanosci. Nanothechnol. 2013, 3, 52-83.

149

Chen, K. L.; Bothun, G. D. Nanoparticles meet cell membranes: Probing non specific interactions using model membranes. Environ. Sci. Technol. 2014, 48, 873-880.

150

Podila, R.; Brown, J. M. Toxicity of engineered nanomaterials: A physicochemical perspective. J. Biochem. Mol. Toxicol. 2013, 27, 50-55.

151

Xu, M. S.; Fujita, D.; Kajiwara, S.; Minowa, T.; Li, X. L.; Takemura, T.; Iwai, H.; Hanagata, N. Contribution of physicochemical characterization of monooxides to cytotoxicity. Biomaterials 2010, 31, 8022-8031.

152

Fenoglio, I.; Greco, G.; Tomatis, M.; Muller, J.; Raymondo-Pinero, E.; Béguin, F.; Fonseca, A.; Nagy, J. B.; Lison, D.; Fubini, B. Structural defects play a major role in the acute lung toxicity of multiwalled carbon nanotubes: physicochemical aspects. Chem. Res. Toxicol. 2008, 21, 1690-1697.

153
National Research Council. Toxicity testing in the 21st century: A vision and strategy, National Academies Press, Washington, DCEdition, 2007. available at http://dels.nas.edu/.
154
National Research Council. Toxicity in the 21st century: The role of the national toxicology program, National Academies Press, Washington, DCEdition, 2004. available at http://ntp.niehs.nih.gov/.
155

Sun, B. B.; Li, R. B.; Wang, X.; Xia, T. Predictive toxicological paradigm and high throughput approach for toxicity screening of engineered nanomaterials. Int. J. Biomed. Nanosci. Nanothechnol. 2013, 3, 4-18.

156

Kim, E. Y.; Schulz, R.; Swantek, P.; Kunstman, K.; Malim, M. H.; Wolinsky, S. M. Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of innate immunity genes. Gene Ther. 2012, 19, 347-353.

157

Patel, S.; Jung, D.; Yin, P. T.; Carlton, P.; Yamamoto, M.; Bando, T.; Sugiyama, H.; Lee, K. B. Nanoscript: A nanoparticle-based artificial transcription factor for effective gene delivey. ACS Nano 2014, 8, 8959-8967.

158

Rauch, J.; Kolch. W.; Laurent, S.; Mahmoudi, M. Big signals from small particles: Regulation of cell signaling pathways by nanoparticles. Chem. Rev. 2013, 113, 3391-3406

159

Xue, J. P.; Shan, L. L.; Chen, H. Y.; Li, Y.; Zhu, H. Y.; Deng, D. W.; Qian, Z. Y.; Achilefu, S.; Gu, Y. Q. Visual detection of STAT5B gene expression in living cells using the hairpin DNA modified gold nanoparticles. Biosens. Bioelectron. 2013, 41, 71-77.

Nano Research
Pages 1771-1799
Cite this article:
Fratoddi I, Venditti I, Cametti C, et al. How toxic are gold nanoparticles? The state-of-the-art. Nano Research, 2015, 8(6): 1771-1799. https://doi.org/10.1007/s12274-014-0697-3

815

Views

240

Crossref

N/A

Web of Science

253

Scopus

8

CSCD

Altmetrics

Received: 01 October 2014
Revised: 11 December 2014
Accepted: 13 December 2014
Published: 09 March 2015
© Tsinghua University Press and Springer-Verlag Berlin Heidelberg 2015
Return